share_log

Novoray (SHSE:688300) Strong Profits May Be Masking Some Underlying Issues

Novoray (SHSE:688300) Strong Profits May Be Masking Some Underlying Issues

聯瑞(上海證券交易所代碼:688300)的強勁利潤可能掩蓋了一些潛在問題
Simply Wall St ·  05/03 08:57

Following the solid earnings report from Novoray Corporation (SHSE:688300), the market responded by bidding up the stock price. Despite this, our analysis suggests that there are some factors weakening the foundations of those good profit numbers.

繼聯瑞公司(SHSE: 688300)發佈穩健的收益報告之後,市場的回應是提高了股價。儘管如此,我們的分析表明,有一些因素削弱了這些良好利潤數字的基礎。

earnings-and-revenue-history
SHSE:688300 Earnings and Revenue History May 3rd 2024
SHSE: 688300 收益和收入歷史記錄 2024 年 5 月 3 日

How Do Unusual Items Influence Profit?

不尋常的物品如何影響利潤?

To properly understand Novoray's profit results, we need to consider the CN¥16m gain attributed to unusual items. While it's always nice to have higher profit, a large contribution from unusual items sometimes dampens our enthusiasm. We ran the numbers on most publicly listed companies worldwide, and it's very common for unusual items to be once-off in nature. And, after all, that's exactly what the accounting terminology implies. If Novoray doesn't see that contribution repeat, then all else being equal we'd expect its profit to drop over the current year.

爲了正確理解聯瑞的盈利業績,我們需要考慮因不尋常項目而獲得的1600萬元人民幣的收益。雖然獲得更高的利潤總是件好事,但來自不尋常物品的巨額捐款有時會抑制我們的熱情。我們統計了全球大多數上市公司的數字,不尋常的物品在自然界中很常見。而且,畢竟,這正是會計術語的含義。如果聯瑞不認爲這種捐款會重演,那麼在其他條件相同的情況下,我們預計其本年度的利潤將下降。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

這可能會讓你想知道分析師對未來盈利能力的預測。幸運的是,您可以單擊此處查看根據他們的估計描繪未來盈利能力的交互式圖表。

Our Take On Novoray's Profit Performance

我們對聯瑞盈利表現的看法

Arguably, Novoray's statutory earnings have been distorted by unusual items boosting profit. Because of this, we think that it may be that Novoray's statutory profits are better than its underlying earnings power. But at least holders can take some solace from the 54% per annum growth in EPS for the last three. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. If you want to do dive deeper into Novoray, you'd also look into what risks it is currently facing. Every company has risks, and we've spotted 1 warning sign for Novoray you should know about.

可以說,Novoray的法定收益被提高利潤的不尋常項目所扭曲。因此,我們認爲可能是聯瑞的法定利潤要好於其基礎盈利能力。但是,至少持有人可以從過去三年的每股收益每年增長54%中得到一些安慰。本文的目標是評估我們在多大程度上可以依靠法定收益來反映公司的潛力,但還有很多需要考慮的地方。如果你想更深入地了解聯瑞,你還需要研究它目前面臨的風險。每家公司都有風險,我們發現了一個你應該知道的Novoray警告信號。

This note has only looked at a single factor that sheds light on the nature of Novoray's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

這份報告只研究了揭示聯瑞利潤性質的單一因素。但是,還有很多其他方法可以讓你對公司的看法。例如,許多人認爲高股本回報率是有利的商業經濟的標誌,而另一些人則喜歡 “關注資金”,尋找內部人士正在買入的股票。因此,你可能希望看到這份免費收藏的擁有高股本回報率的公司,或者這份內部人士正在購買的股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論